Inhalational anesthesia for organ procurement: Potential indications for administering inhalational anesthesia in the brain-dead organ donor

AANA Journal

Volumn 78, Issue 4, 2010, Pages 293-299

  Elkins, Laurie J ^a  

^a CHARLESTON AREA MEDICAL CENTER   (United States)

Author keywords

Brain dead organ donor; Inhalational anesthesia; Organ procurement

Indexed keywords

ADRENALIN; ALBUMIN; ARGININE; ARGIPRESSIN; CATECHOLAMINE; DESMOPRESSIN; ESMOLOL; FENTANYL; FRESH FROZEN PLASMA; HYDROCORTISONE; INHALATION ANESTHETIC AGENT; INSULIN; ISOFLURANE; LIOTHYRONINE; METHYLPREDNISOLONE; NEUROMUSCULAR BLOCKING AGENT; NICARDIPINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NITROUS OXIDE; NORADRENALIN; THYROXINE; TUMOR NECROSIS FACTOR ALPHA; URAPIDIL; VASOPRESSIN;

AUTONOMIC DYSFUNCTION; AUTONOMIC STORM; BRAIN DEATH; CATECHOLAMINE RELEASE; CONTINUOUS INFUSION; CYTOKINE RELEASE; DEHYDRATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG HALF LIFE; ELECTROLYTE DISTURBANCE; ERYTHROCYTE CONCENTRATE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTENSION; HYPOTHERMIA; HYPOVOLEMIA; INHALATION ANESTHESIA; ISCHEMIA; ISCHEMIC PRECONDITIONING; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; REPERFUSION INJURY; REVIEW; THROMBOCYTE AGGREGATION; TREATMENT INDICATION; DONOR; NURSE ANESTHETIST; PROCEDURES;

ANESTHESIA, INHALATION; BRAIN DEATH; HUMANS; ISCHEMIC PRECONDITIONING; NURSE ANESTHETISTS; TISSUE DONORS;

EID: 77957672691     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Arbour R. Clinical management of the organ donor. AACN Clin Issues. 2005;16(4):551-580.
2. Sarti A. Organ donation. Paediatr Anaesth. 1999(4);9:287-294.
3. Peiffer KM. Brain death and organ procurement. Am J Nurs. 2007;107 (3):58-67.
4. Audibert G, Charpentier C, Seguin-Devaux C, et al. Improvement of donor myocardial function after treatment of autonomic storm during brain death. Transplantation. 2006;82(8):1031-1036.
5. Kutsogiannis DJ, Pagliarello G, Doig C, Ross H, Shemie SD. Medical management to optimize donor organ potential: review of the literature. Can J Anesth. 2006;53(8):820-830. (Pubitemid 44424229)
6. Novitzky D, Cooper DK, Rosendale JD, Kauffman HM. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation. 2006;82(11):1396-1401.
7. Avlonitis VS, Fisher AJ, Kirby JA, Dark JH. Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation. 2003;75(12): 1928-1933. (Pubitemid 36793270)
8. Spiss CK, Metnitz PH, Schafer B, Steltzer H. Management of the multi-organ donor. Acta Anaesthesiol Scand Suppl. 1997;111:77-78.
9. Nijboer WN, Schuurs TA, van der Hoeven JA,et al. Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation. 2004;78(7):978-986.
10. Szabo G, Soós P, Heger U, et al. L-Arginine improves endothelial and myocardial function after brain death. Transplantation. 2006;82(1): 108-112.
11. Kaminska D, Tyran B, Mazanowska O, et al. Cytokine gene expression in kidney allograft biopsies after donor brain death and ischemiareperfusion injury using in situ reverse-transcription polymerase chain reaction analysis. Transplantation. 2007;84(9):1118-1124.
12. Sanchez-Fructuoso Al, Prats D, Marques M, et al. Does donor brain death influence acute vascular rejection in the kidney transplant? Transplantation. 2004;78(1): 142-146. (Pubitemid 38938298)
13. Ullah S, Zabala L, Watkins B, Schmitz ML. Cardiac organ donor management. Perfusion. 2006;21(2):93-98.
14. Zuppa AF, Nadkami V, Davis L, et al. The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function. Crit Care Med. 2004;32(11):2318-2322. (Pubitemid 39491815)
15. Rostron AJ, Avlonitis VS, Cork DM, Grenade DS, Kirby JA, Dark JH. Hemodynamic resuscitation with arginine vasopressin reduces lung injury after brain death in the transplant donor. Transplantation. 2008;85(4):597-606.
16. Elliot JM. Brain death. Trauma. 2003;5:23-42.
17. Berry R. Brainstem death and the management of the organ donor. Anaesth Intensive Care Med. 2006;7(6):212-214. (Pubitemid 44882779)
18. Munn J. Focus on: medico-legal issues in anaesthesia - part 1. Brainstem death and organ donation. Curr Anaesth Crit Care. 1998;9(5):236-241.
19. Fitzgerald RD, Hieber C, Schweitzer E, Luo A, Oczenski W, Lackner FX. Intraoperative catecholamine release in brain-dead organ donors is not suppressed by administration of fentanyl. Eur J Anaesthesiol 2003;20(12):952-956. (Pubitemid 37500222)
20. Young PJ, Malta BE Anaesthesia for organ donation in the brainstem dead - why bother? Anaesthesia. 2000;55(2): 105-106.
21. Wetzel RC, Setzer N, Stiff JL, Rogers MC. Hemodynamic responses in brain dead organ donor patients. Anesth Analg. 1985;64(2):125-128.
22. Otte JB, Squifflet JP, Carlier MC, et al. Organ procurement in children: surgical, anaesthetic and logistic aspects. Intensive Care Med. 1989;15: S67-S70.
23. Yoo KY, Jeong CW, Kim SJ, et al. Sevoflurane concentrations required to block autonomic hyperreflexia during transurethral litholapaxy in patients with complete spinal cord injury. Anesthesiology. 2008;108 (5):858-863.
24. Mollaret P, Goulon M. Le coma depasse. Rev Neurol 1959;101:3-15.
25. Cardio-thoracic donor management. In: Critical pathway for the organ donor. United Network for Organ Sharing website. http://www. unos.org/resources/pdfs/CriticalPathwayPoster.pdf. Published 2002. Accessed November 15, 2008.
26. Matuschak GM. Optimizing ventilatory support of the potential organ donor during evolving brain death: maximizing lung availability for transplantation. Crit Care Med. 2006;34(2):548-549.
27. Koudstaal LG, 't Hart NA, Ottens PJ, et al. Brain death induces inflammation in the donor intestine. Transplantation. 2008;86(1): 148-154.
28. Gelb AW, Robertson KM. Anaesthetic management of the brain dead for organ donation. Can J Anesth. 1990;37(7):806-812. (Pubitemid 20335419)
29. Antognini JF, Berg K. Cardiovascular responses to noxious stimuli during isoflurane anesthesia are minimally affected by anesthetic action in the brain. Anesth Analg. 1995;81(4):843-848.
30. De Hert SG, Turani F, Mathur S, Stowe DE Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg. 2005;100(6):1584-1593. (Pubitemid 40712704)
31. Hashiguchi H, Morooka H, Miyoshi H, Matsumoto M, Koji T, Sumikawa K. Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK. Anesth Analg. 2005;101(6):1584-1589. (Pubitemid 41720601)
32. Weber NC, Kandler J, Schlack W, Grueber Y, Fradorf J, Preckel B. Intermitted [sic] pharmacologic pretreatment by xenon, isoflurane, nitrous oxide, and the opioid morphine prevents tumor necrosis factor ct-induced adhesion molecule expression in human umbilical vein endothelial cells. Anesthesiology. 2008;108(2):199-207.